Skip to content
Triangle logo TriangleGet started
← Back to this collection

PUBLICATIONS · 32043763

Health-Related Quality of Life in MONARCH 2: Abemaciclib plus Fulvestrant in Hormone Receptor-Positive, HER2-Negative Advanced Breast Cancer After Endocrine Therapy.

Open original source → · Download preserved record

Bibliographic metadata only. No full-text article or abstract is reproduced. Absence of a captured notice is not confirmation that a publication is clear of corrections or retractions.

Journal
Oncologist
Publication date
2020 Feb
First author
Kaufman PA

Publication notices

absence is not clearance
true
has correction metadata
false
has expression of concern metadata
false
has retraction in link
false
pubmed marks article retracted
false
pubmed marks retraction notice
false
relationships

    Authors and identifiers

    1. name
      Kaufman PA
      type
      Author
    2. name
      Toi M
      type
      Author
    3. name
      Neven P
      type
      Author
    4. name
      Sohn J
      type
      Author
    5. name
      Grischke EM
      type
      Author
    6. name
      Andre V
      type
      Author
    7. name
      Stoffregen C
      type
      Author
    8. name
      Shekarriz S
      type
      Author
    9. name
      Price GL
      type
      Author
    10. name
      Carter GC
      type
      Author
    11. name
      Sledge GW Jr
      type
      Author
    Complete bibliographic record and source provenance
    authors
    1. name
      Kaufman PA
      type
      Author
    2. name
      Toi M
      type
      Author
    3. name
      Neven P
      type
      Author
    4. name
      Sohn J
      type
      Author
    5. name
      Grischke EM
      type
      Author
    6. name
      Andre V
      type
      Author
    7. name
      Stoffregen C
      type
      Author
    8. name
      Shekarriz S
      type
      Author
    9. name
      Price GL
      type
      Author
    10. name
      Carter GC
      type
      Author
    11. name
      Sledge GW Jr
      type
      Author
    bibliography ids
    1. nci-bib-925fa7953b1fe51393613931
    book metadata
    content sha256
    4256753724b435737555cf8f07209b9142187593117b15349492d8644df6ebc8
    document type
    citation
    dois
    1. 10.1634/theoncologist.2019-0551
    electronic publication date
    display
    2019 Oct 24
    precision
    day
    year
    2019
    evidence scope
    bibliographic_metadata_only
    id
    pubmed:32043763
    immutable id
    pubmed:32043763@4256753724b435737555cf8f07209b9142187593117b15349492d8644df6ebc8
    journal
    abbreviation
    Oncologist
    issn electronic
    1549-490X
    issn print
    1083-7159
    issue
    2
    name
    The oncologist
    nlm unique id
    9607837
    pages
    e243-e251
    volume
    25
    languages
    1. eng
    notices
    absence is not clearance
    true
    has correction metadata
    false
    has expression of concern metadata
    false
    has retraction in link
    false
    pubmed marks article retracted
    false
    pubmed marks retraction notice
    false
    relationships
      outcomes validated
      false
      pmid
      32043763
      provenance
      batch id
      4c5003fbb78890e89ae1
      provider
      NCBI PubMed ESummary
      record sha256
      ff8ffff58df449bcb0df2977db78475109e1610b6d0078a0a785cbeb21943ef8
      response sha256
      890389583ce193a9c74e19c63678e418dad2088e82cb704b888b02fcc887d269
      retrieved at
      2026-09-09T23:47:48.270700+00:00
      publication date
      display
      2020 Feb
      precision
      month
      year
      2020
      publication types
      1. Journal Article
      2. Randomized Controlled Trial
      3. Research Support, Non-U.S. Gov't
      record status
      PubMed - indexed for MEDLINE
      schema version
      1.0
      source url
      https://pubmed.ncbi.nlm.nih.gov/32043763/
      title
      Health-Related Quality of Life in MONARCH 2: Abemaciclib plus Fulvestrant in Hormone Receptor-Positive, HER2-Negative Advanced Breast Cancer After Endocrine Therapy.

      Preserved source evidence · Not medical advice